ClinicalTrials.Veeva

Menu

AI-based Low Dose CBCT Reconstruction for Clinical Application

H

Huazhong University of Science and Technology

Status

Not yet enrolling

Conditions

Lung Nodule

Treatments

Other: AI-based low dose CBCT reconstructed images system
Other: Conventional CBCT images system

Study type

Interventional

Funder types

Other

Identifiers

NCT06831617
AI guidance-Lung 001

Details and patient eligibility

About

The goal of this clinical trial is to learn if AI-based low dose CBCT reconstructed images can guide lung puncture effectively. The main questions it aims to answer are:

  1. Does the AI-based low dose CBCT reconstruction model reconstruct high quality images?
  2. Is it possible that low-dose CBCT reconstructed images can guide lung puncture procedures without compromising the efficiency of the procedure? Researchers will compare AI-based low dose CBCT reconstructed images to a placebo (conventional CBCT images) to see if AI-based low dose CBCT reconstructed image can guide lung puncture procedures without compromising the efficiency of the procedure.

Participants will:

  1. Undergo lung puncture under AI-based low dose CBCT reconstructed images guidance or under conventional CBCT images
  2. Be followed up for 1 week postoperative to obtain patient complications

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants who require CBCT-guided precutaneous lung puncture (PLP) and meet the clinical indications for the procedure.
  • Participants whose physical condition is suitable for PLP.
  • Participants are willing to sign informed consent.

Exclusion criteria

  • Participants have metallic implants in the body, which severely affects the image quality.
  • Participants are pregnant or breastfeeding.
  • Participants are unwilling or unable to sign informed consent.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

400 participants in 2 patient groups, including a placebo group

AI based CBCT reconstructed images guided lung puncture
Experimental group
Description:
Participants in the experimental group undergo AI-based low dose (radiation dose is 1/6th of the dose used in the clinic) CBCT reconstructed images guided lung puncture procedures.
Treatment:
Other: AI-based low dose CBCT reconstructed images system
Conventional CBCT images guided lung puncture
Placebo Comparator group
Description:
Participants in the experimental group undergo conventional CBCT images guided lung puncture procedures.
Treatment:
Other: Conventional CBCT images system

Trial contacts and locations

3

Loading...

Central trial contact

Huangxuan Zhao, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems